PATENT CLAIM ANALYSIS

Application Number: 16072278
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["544", "318000"]

Abstract:
The invention relates to compounds of Formula (I), (II), (III) or (IV), salts thereof, pharmaceutical compositions thereof, as well as methods of treating, curing or preventing HIV in subjects.

Claim (Index 25):
A compound of the structure according to formula (II): or a pharmaceutically acceptable salt thereof, wherein:\n X is selected from O or N, wherein when X is O, then R 3  is absent; \n R 1  is optionally present, and when present, is selected from the group consisting of \u2014H and \u2014C(O)R 4 , and wherein the group: \n is represented as: R 2  and R 3  are independently selected from the group consisting of \u2014H, \u2014C(O)R 10 , and \u2014C(O)N(R 6 )(R 7 ) and wherein when X is N, then R 2  and R 3  may be taken together to form 1,3-dioxoisoindolin-2-yl; R 4  is R 6  and R 7  selected from methyl and 4-chlorophenyl; R 10  is selected from the group consisting of methyl and phenyl; and with the proviso that when X is O and R 2  is H, R 1  is not present.

Metadata:
- Claim Count in Document: 51.0
- Percentile: 95.0
- Lexical Diversity: 1.51724
- Patent Class: 544.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14956586', '14001132', '15427303', '15635454', '13811207']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7935982398342728
- 35 USC 102 Novelty (BERT): 0.5242251096594034
- Combined Prediction Score: 0.7666609268167859
- Mean Citation Score: 315.0160600000001
- Max Citation Score: 330.4619
- Similarity Product: 240.8850294929206

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test